Digestive Disease Center, Soonchunhyang University Hospital
Seoul, 140-887, South Korea
NCT Number: NCT01753544
We aim to evaluate safety and feasibility of a thulium laser system in performing endoscopic submucosal dissection of gastric neoplasia.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Observational
Seoul, 140-887, South Korea
Instead of endoscopic knives, a thin, flexible fiber is inserted through the working channel of the endoscope. Acetic acid (1.5%) and indigo carmine dye are sprayed onto the lesion to clarify the margin. Markings are made 10 mm outside the tumor margin using a laser fiber with a power setting at 30 W. After marking, a mixture of sodium hyaluronate with indigo carmine and epinephrine (1:25000) is injected into the submucosa outside the marking dots. A circumferential mucosal incision and submucosal dissection are performed by a thulium laser fiber with a power setting at 30 to 40 W. Activation of the laser beam is controlled by stepping on a foot pedal. Hemostasis during procedure is also attempted using the thulium laser. When hemostasis is not achieved properly, additional use of hemostatic forceps or a hemoclip will be considered.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
Curative resection rate
Time frame: 7 days
Procedure-related bleeding, perforation
Soonchunhyang University Hospital
Other
Endoscopic Submucosal Dissection Using a Thulium Laser: Preliminary Results of a New Method for Treatment of Gastric Epithelial Neoplasia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01523912
Gastric Dysplasia, Neoplasia
Porto, Portugal
View Trial DetailsNCT01614418
Gastric Dysplasia, Intestinal Metaplasia
Hong Kong
View Trial DetailsNCT01688687
Digestive System Diseases, Digestive System Neoplasms
Seoul, South Korea
View Trial DetailsNCT07312370
Digestive System Diseases, Digestive System Neoplasms
Lanzhou, Gansu, China
View Trial Details